Cargando…
Multidisciplinary treatment of a patient with severe immune checkpoint inhibitor-induced colitis: A case report
BACKGROUND: Immune checkpoint inhibitors (ICIs) are a new class of antitumor drugs that have been approved to treat a variety of malignant tumors. However, the occurrence of immune related adverse events (irAEs) has become an important reason for terminating treatment. ICIs sometimes lead to diarrhe...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782922/ https://www.ncbi.nlm.nih.gov/pubmed/36569020 http://dx.doi.org/10.12998/wjcc.v10.i35.13108 |